Proposed Data Collections Submitted for Public Comment and Recommendations, 81613-81614 [2010-32588]

Download as PDF Federal Register / Vol. 75, No. 248 / Tuesday, December 28, 2010 / Notices FOR FURTHER INFORMATION CONTACT: Brian Chiglinsky, 202–260–6090. Press inquiries are handled through OCIIO’s Press Office at (202) 690–6343. SUPPLEMENTARY INFORMATION: emcdonald on DSK2BSOYB1PROD with NOTICES I. Background The purpose of the meeting is to assist and advise the Secretary and Congress through the Department of Health and Human Services’ Office of Consumer Information and Insurance Oversight (OCIIO) on the Department’s strategy to foster the creation of qualified nonprofit health insurance issuers. Specifically, the Committee shall advise the Secretary and Congress concerning the award of grants and loans related to Section 1322 of the Affordable Care Act. In these matters, the Committee shall consult with all components of the Department, other federal entities, and non-federal organizations, as appropriate; and examine relevant data sources to assess the grant and loan award strategy to provide recommendations to OCIIO. II. Meeting Agenda The committee will hear testimony from a number of individuals with experience and expertise in the market for health insurance and nonprofit cooperative health issuers. OCIIO intends to make background material available to the public no later than two (2) business days prior to the meeting. If OCIIO is unable to post the background material on its Web site prior to the meeting, it will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on OCIIO’s Web site after the meeting, at https://hhs.gov/ociio. Oral comments from the public will be scheduled between approximately 3 p.m. to 4 p.m. Individuals or organizations that wish to make a 3-minute oral presentation on an agenda topic should submit a written copy of the oral presentation to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. The number of oral presentations may be limited by the time available. Persons attending OCIIO’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. If the number of speakers requesting to comment is greater than can be reasonably accommodated during the scheduled open public comment session, OCIIO will take written comments after the meeting until close of business. Individuals not wishing to make a presentation may submit written VerDate Mar<15>2010 22:37 Dec 27, 2010 Jkt 223001 comments to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. Individuals requiring sign language interpretation or other special accommodations must contact the DFO via the contact information specified in the FOR FURTHER INFORMATION CONTACT section of this notice by the date listed in the DATES section of this notice. OCIIO is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://www.hhs.gov/ociio for procedures on public conduct during advisory committee meetings. Dated: December 21, 2010. Barbara Smith, Associate Director, Consumer Operated and Oriented Plan Program, Office of Consumer Information and Insurance Oversight. [FR Doc. 2010–32649 Filed 12–27–10; 8:45 am] BILLING CODE 4150–45–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–11–11BI] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Carol Walker, Acting CDC Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 81613 technology. Written comments should be received within 60 days of this notice. Proposed Project FoodNet Non-O157 Shiga ToxinProducing E. coli Study: Assessment of Risk Factors for Laboratory-Confirmed Infections and Characterization of Illnesses by Microbiological Characteristics—New—National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC). Background and Brief Description Each year many Shiga toxinproducing E. coli (STEC) infections occur in the United States, ranging in severity from mild diarrhea, to hemorrhagic colitis and in some cases, life-threatening hemolytic uremic syndrome (HUS). HUS occurs most frequently following infection with serogroup O157; 6% of patients with this type of STEC infection develop HUS, with highest occurrence in children aged <5 years. HUS has a fatality rate of approximately 5%; up to 25% of HUS survivors are left with chronic kidney damage. STEC are broadly categorized into two groups by their O antigens, STEC O157 and non-O157 STEC. The serogroup O157 is most frequently isolated and most strongly associated with HUS. Risk factors for STEC O157 infections in the United States and internationally have been intensely studied. Non-O157 STEC are a diverse group that includes all Shiga toxin-producing E. coli of serogroups other than O157. Over 50 STEC serogroups are known to have caused human illness. Numerous nonO157 outbreaks have been reported from throughout the world and clinical outcomes in some patients can be as severe as those seen with STEC O157 infections, however, little is known about the specific risk factors for infections due to non-O157 STEC serogroups. More comprehensive understanding of risk factors for sporadic non-O157 STEC infections is needed to inform prevention and control efforts. The FoodNet casecontrol study will be the first multistate investigation of non-outbreak-associated non-O157 STEC infections in the United States. It will investigate risk factors for non-O157 STEC infections, both as a group and individually for the most common non-O157 STEC serogroups. In addition, the study will characterize the major known virulence factors of nonO157 STEC to assess how risk factors and clinical features vary by virulence factor profiles. As the largest, most comprehensive, and most powerful E:\FR\FM\28DEN1.SGM 28DEN1 81614 Federal Register / Vol. 75, No. 248 / Tuesday, December 28, 2010 / Notices study of its kind, it could make an important contribution towards better understanding of non-O157 STEC infections and to providing sciencebased recommendations for interventions to prevent these infections. Persons with non-O157 STEC infections who are identified as part of routine public health surveillance and randomly selected healthy persons in the patients’ communities (to serve as controls) will be contacted and offered enrollment into this study. Participation is completely voluntary and there is no cost for enrollment. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Patients ............................................................................................................ Controls ............................................................................................................ 161 483 1 1 25/60 25/60 67 201 Total .......................................................................................................... ........................ ........................ ........................ 268 Dated: December 21, 2010. Carol Walker, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2010–32588 Filed 12–27–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request Title: Office of Community Services (OCS) Community Economic Development (CED) and Job Opportunities for Low-Income Individuals (JOLI) Standard Reporting Format. OMB No.: New Collection. Description: The Office of Community Services (OCS) is collecting key information about projects funded through the Community Economic Development (CED) and Job Opportunities for Low-Income Individuals (JOLI) programs. The legislative requirement for these two programs is in Title IV of the Community Opportunities, Accountability and Training and Educational Services Act (COATS Human Services Reauthorization Act) of October 27, 1998, Public Law 105–285, section 680(b) as amended. The Performance Progress Report (PPR) is a new proposed reporting format that will collect information concerning the outcomes and management of CED and JOLI projects. OCS will use the data to critically review the overall design and effectiveness of each program. The PPR will be administered to all active grantees of the CED and JOLI programs. Grantees will be required to use this reporting tool for their semiannual reports. The majority of the questions in this tool were adapted from a previously approved questionnaire, Office of Management and Budget (OMB) Control Number: 0970–0317. Questions were also adapted to the OMB-approved reporting format of the PPR, specifically forms SF–PPR, SF– PPR–A, SF–PPR–B, and SF–PPR–E. Additional changes were made to improve the clarity and quality of the data and to eliminate unnecessary questions. The PPR will replace both the annual questionnaire and the current semi-annual reporting format, which will result in an overall reduction in burden for the grantees while significantly improving the quality of the data collected by OCS. Respondents: Current CED and JOLI grantees. TABLE 1—ANNUAL BURDEN ESTIMATE Number of responses Number of responses per respondent Average burden hours per response PPR Forms for current OCS JOLI grantees .................................................... PPR Forms for current OCS CED grantees .................................................... Estimated Annual Burden Hours ..................................................................... emcdonald on DSK2BSOYB1PROD with NOTICES Instrument 40 170 ........................ 2 2 ........................ 1.5 1.5 ........................ Estimated Total Annual Burden Hours: 630. Additional Information: Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L’Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. E-mail address: infocollection@acf.hhs.gov. VerDate Mar<15>2010 22:37 Dec 27, 2010 Jkt 223001 OMB Comment: OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Fax: 202– PO 00000 Frm 00055 Fmt 4703 Sfmt 9990 Total burden hours 120 510 630 395–7285, E-mail: OIRA_SUBMISSION@OMB.EOP.GOV, Attn: Desk Officer for the Administration for Children and Families. Dated: December 21, 2010. Robert Sargis, Reports Clearance Officer. [FR Doc. 2010–32509 Filed 12–27–10; 8:45 am] BILLING CODE P E:\FR\FM\28DEN1.SGM 28DEN1

Agencies

[Federal Register Volume 75, Number 248 (Tuesday, December 28, 2010)]
[Notices]
[Pages 81613-81614]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32588]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-11-11BI]

Proposed Data Collections Submitted for Public Comment and
Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Carol Walker, Acting CDC Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.

Proposed Project

FoodNet Non-O157 Shiga Toxin-Producing E. coli Study: Assessment of
Risk Factors for Laboratory-Confirmed Infections and Characterization
of Illnesses by Microbiological Characteristics--New--National Center
for Emerging and Zoonotic Infectious Diseases, Centers for Disease
Control and Prevention (CDC).

Background and Brief Description

Each year many Shiga toxin-producing E. coli (STEC) infections
occur in the United States, ranging in severity from mild diarrhea, to
hemorrhagic colitis and in some cases, life-threatening hemolytic
uremic syndrome (HUS). HUS occurs most frequently following infection
with serogroup O157; 6% of patients with this type of STEC infection
develop HUS, with highest occurrence in children aged <5 years. HUS has
a fatality rate of approximately 5%; up to 25% of HUS survivors are
left with chronic kidney damage.
STEC are broadly categorized into two groups by their O antigens,
STEC O157 and non-O157 STEC. The serogroup O157 is most frequently
isolated and most strongly associated with HUS. Risk factors for STEC
O157 infections in the United States and internationally have been
intensely studied. Non-O157 STEC are a diverse group that includes all
Shiga toxin-producing E. coli of serogroups other than O157. Over 50
STEC serogroups are known to have caused human illness. Numerous non-
O157 outbreaks have been reported from throughout the world and
clinical outcomes in some patients can be as severe as those seen with
STEC O157 infections, however, little is known about the specific risk
factors for infections due to non-O157 STEC serogroups. More
comprehensive understanding of risk factors for sporadic non-O157 STEC
infections is needed to inform prevention and control efforts. The
FoodNet case-control study will be the first multistate investigation
of non-outbreak-associated non-O157 STEC infections in the United
States. It will investigate risk factors for non-O157 STEC infections,
both as a group and individually for the most common non-O157 STEC
serogroups. In addition, the study will characterize the major known
virulence factors of non-O157 STEC to assess how risk factors and
clinical features vary by virulence factor profiles. As the largest,
most comprehensive, and most powerful

[[Page 81614]]

study of its kind, it could make an important contribution towards
better understanding of non-O157 STEC infections and to providing
science-based recommendations for interventions to prevent these
infections.
Persons with non-O157 STEC infections who are identified as part of
routine public health surveillance and randomly selected healthy
persons in the patients' communities (to serve as controls) will be
contacted and offered enrollment into this study. Participation is
completely voluntary and there is no cost for enrollment.

Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Respondents respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Patients........................................ 161 1 25/60 67
Controls........................................ 483 1 25/60 201
---------------------------------------------------------------
Total....................................... .............. .............. .............. 268
----------------------------------------------------------------------------------------------------------------

Dated: December 21, 2010.
Carol Walker,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2010-32588 Filed 12-27-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.